ProPhase Labs Just Filed Its Quarterly Report: A reconciliation of...

A reconciliation of the applicable numerators and denominators of the income statement periods presented, as reflected in the results of continuing operations, is as follows (in thousands, except per share amounts):

 

    Three Months Ended     Three Months Ended     Nine Months Ended     Nine Months Ended  
    September 30, 2016     September 30, 2015     September 30, 2016     September 30, 2015  
    Income     Shares     EPS     Income     Shares     EPS     Loss     Shares     EPS     Loss     Shares     EPS  
Basic income (loss) per share   $ 167       17,081     $ 0.01     $ 602       16,597     $ 0.04     $ (2,296 )     17,081     $ (0.13 )   $ (2,344 )     16,171     $ (0.14 )
                                                                                                 
Dilutives:                                                                                                
Options     -       519       -       -       375       -       -       -       -       -       -       -  
                                                                                                 
Diluted income (loss) per share   $ 167       17,600     $ 0.01     $ 602       16,972     $ 0.04     $ (2,296 )     17,081     $ (0.13 )   $ (2,344 )     16,171     $ (0.14 )

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever ProPhase Labs makes a similar move, sign up!

Other recent filings from the company include the following:

ProPhase Labs's Chief Financial Officer just picked up 360,000 shares - Sept. 15, 2017
Tender offer statement by Issuer - Aug. 25, 2017
Departure of Directors or Certain - Aug. 24, 2017

Auto Refresh

Feedback